Legal and Regulatory Summit on Generic Drugs

July 24-25, 2014

The Carlton Hotel
New York, NY

Partner Timothy H. Kratz spoke on the topic "Exploring Strategies for Biosimilar Development in the United States; Regulatory, IP & Commercial Considerations Gleaned from the Global Framework" at this event hosted by the American Conference Institute. The conference addresses new requirements of the Generic Drug User Fee Act, the evolving risk of product liability exposure, and REMS issues facing the generic pharmaceutical industry. For additional details, please visit www.americanconference.com.